✦ LIBER ✦

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma : Risk factors and clinical consequences

✍ Scribed by Montserrat Vera-Llonch; Gerry Oster; May Hagiwara; Stephen Sonis

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 90 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21622

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gabapentin for the treatment of pain rel

Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy

✍ Voichita Bar Ad; Gregory Weinstein; Pinaki R. Dutta; Ara Chalian; Stefan Both; H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract ## __Background.__ This retrospective study evaluates the efficacy of gabapentin for the treatment of pain syndrome related to radiation‐induced mucositis in patients with head and neck tumors. ## __Methods.__ Thirty cases of head and neck malignancies treated with radiotherapy were

Gabapentin for the treatment of pain syn

Gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy

✍ Voichita Bar Ad; Gregory Weinstein; Pinaki R. Dutta; Arie Dosoretz; Ara Chalian; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

Hyperfractionated radiation therapy and

Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma

✍ André A. Abitbol; Kasi S. Sridhar; Alan A. Lewin; James G. Schwade; William Raub 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 3 views

initial entry of 34 patients. Cancer Center, University of Miami School of RESULTS. At a median follow-up of 41 months (range, 12-80 months), 44 patients Medicine, Miami, Florida. were alive with a projected median overall survival of 54 months. Grade 3/4 muco-2 Regional Cancer Center, Baptist Hosp

Therapeutic effect of recombinant human

Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer : A double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial

✍ Hong Gyun Wu; Si Yeol Song; Yeon Sil Kim; Young Taek Oh; Chang Geol Lee; Ki Chan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views